Dashboard
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 4.61% and Operating profit at -51.86% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 8.20% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 4.61% and Operating profit at -51.86% over the last 5 years
3
With a fall in Net Sales of -7.67%, the company declared Very Negative results in Mar 26
4
Risky -
Stock DNA
Other Agricultural Products
CNY 9,588 Million (Mid Cap)
NA (Loss Making)
NA
1.10%
0.48
-0.66%
1.40
Revenue and Profits:
Net Sales:
3,917 Million
(Quarterly Results - Mar 2026)
Net Profit:
-173 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.61%
0%
-11.61%
6 Months
0.28%
0%
0.28%
1 Year
9.77%
0%
9.77%
2 Years
5.83%
0%
5.83%
3 Years
-13.97%
0%
-13.97%
4 Years
-38.06%
0%
-38.06%
5 Years
-5.47%
0%
-5.47%
Tecon Biology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.61%
EBIT Growth (5y)
-51.86%
EBIT to Interest (avg)
-0.52
Debt to EBITDA (avg)
3.19
Net Debt to Equity (avg)
0.42
Sales to Capital Employed (avg)
1.39
Tax Ratio
100.00%
Dividend Payout Ratio
50.55%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.56%
ROE (avg)
8.20%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.16
EV to EBIT
224.64
EV to EBITDA
16.72
EV to Capital Employed
1.11
EV to Sales
0.67
PEG Ratio
NA
Dividend Yield
1.33%
ROCE (Latest)
0.49%
ROE (Latest)
-0.66%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
3,916.80
3,370.70
16.20%
Operating Profit (PBDIT) excl Other Income
-131.30
-9.00
-1,358.89%
Interest
35.20
47.20
-25.42%
Exceptional Items
0.70
0.50
40.00%
Consolidate Net Profit
-172.50
-204.60
15.69%
Operating Profit Margin (Excl OI)
-33.50%
-61.50%
2.80%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 16.20% vs -29.24% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 15.69% vs -314.92% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
16,977.30
17,156.10
-1.04%
Operating Profit (PBDIT) excl Other Income
1,212.20
1,633.40
-25.79%
Interest
162.50
193.30
-15.93%
Exceptional Items
-15.60
-40.80
61.76%
Consolidate Net Profit
300.30
596.40
-49.65%
Operating Profit Margin (Excl OI)
21.50%
42.70%
-2.12%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -1.04% vs -9.60% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -49.65% vs 139.33% in Dec 2024
About Tecon Biology Co., Ltd. 
Tecon Biology Co., Ltd.
Other Agricultural Products
No Details Available.
Company Coordinates 
No Company Details Available






